Evidence map›Paper›PMID 41480243›Full record

ArticleQatar medical journal2025

Evaluation of potentially significant drug-drug interactions among patients receiving psychotropic medications: A real-world retrospective study.

Rania Abu-Kuhail, Oraib Abdallah, Mohammed Abu-Hafizah, Shatha Alqam, Yassin Eltorki, Nosyba Ez Eldeen, Sali El Hoseny, Noriya Al-Khuzaei

Abstract read
In one paragraph

Article in Qatar medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rania Abu-KuhailPharmacy Department, Mental Health Services, Hamad Medical Corporation, Doha, Qatar *Email: rabukuhail@hamad.qa.
Oraib AbdallahPharmacy Department, Mental Health Services, Hamad Medical Corporation, Doha, Qatar *Email: rabukuhail@hamad.qa.
Mohammed Abu-HafizahPharmacy Department, Mental Health Services, Hamad Medical Corporation, Doha, Qatar *Email: rabukuhail@hamad.qa.
Shatha AlqamPharmacy Department, Mental Health Services, Hamad Medical Corporation, Doha, Qatar *Email: rabukuhail@hamad.qa.
Yassin EltorkiPharmacy Department, Mental Health Services, Hamad Medical Corporation, Doha, Qatar *Email: rabukuhail@hamad.qa.
Nosyba Ez EldeenPharmacy Department, Mental Health Services, Hamad Medical Corporation, Doha, Qatar *Email: rabukuhail@hamad.qa.
Sali El HosenyPharmacy Department, Mental Health Services, Hamad Medical Corporation, Doha, Qatar *Email: rabukuhail@hamad.qa.
Noriya Al-KhuzaeiPharmacy Department, Mental Health Services, Hamad Medical Corporation, Doha, Qatar *Email: rabukuhail@hamad.qa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Drug-drug interactions (DDIs) can lead to adverse events or altered drug effectiveness, and polypharmacy increases the likelihood of DDIs. This study aimed to explore the prevalence of clinically significant DDIs among patients with mental health problems who are prescribed psychotropic medications. Methodology: This was a retrospective observational study that included patients who had visited the Outpatient Mental Health Pharmacy at Mental Health Services (MHS) in Qatar for medication dispensing. The study covered all individuals over 2 months, totaling 1586 patients. The list of medications was cross-referenced with Lexicomp Results: Of the 1586 files reviewed, 49% of the patients did not experience any DDIs, while the remaining 51% ( Conclusions: The study provided valuable insight into the prevalence of potential DDIs among patients prescribed psychotropic medications in Qatar. Notably, the analysis highlighted significant interactions, particularly those associated with severe outcomes, like Torsades de Pointes and anticholinergic intoxication. These findings underscore the need for targeted strategies to mitigate adverse effects and enhance patient safety in clinical practice.

Indexed as

Drug interactionsmental illnesspsychotropicsQatar

Identifiers

PMID41480243
PMCPMC12754182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.